1.Infection of human papillomavirus and head and neck cancer.
Cheng SONG ; Shao Kai ZHANG ; You Lin QIAO
Chinese Journal of Oncology 2023;45(1):39-43
High-risk human papillomavirus (HPV)-related cancers consist of cervical cancer, anal cancer, penile cancer, vulvar cancer, vaginal cancer, and head and neck cancer (HNC). Of these, the disease burden of HNC is second only to cervical cancer. HNC mostly originates from malignant lesions of squamous epithelial cells and mainly includes oral cavity cancer, pharyngeal cancer (including nasopharyngeal cancer, oropharyngeal cancer, and hypopharyngeal cancer), and laryngeal cancer. Tobacco use, alcohol abuse, and HPV infection are three primary risk factors. Recently, there is an upward trend of HNC incidence globally, especially in high-income countries. In China, the disease burden and trends of HPV-related HNC are still not clear. A few small sample size and single-center studies suggest a high HPV prevalence and increasing trend in HNC. Methodological differences in HPV testing and regional variabilities still exist among these studies. Among the anatomic sites, oropharyngeal cancer has been shown to be caused by HPV infection, but the association of HPV with other sites is still under debate. In addition, there is a paucity of relevant studies. Here, this review narrates the association between HPV infection and HNC, compares the differences between global and Chinese studies, and then explores the importance of HPV infection in various anatomical sites. The main objective is to highlight the research on HPV-related HNC and promote relevant prevention and treatment programs.
Female
;
Humans
;
Human Papillomavirus Viruses
;
Papillomavirus Infections/prevention & control*
;
Uterine Cervical Neoplasms/complications*
;
Nasopharyngeal Neoplasms/complications*
;
Head and Neck Neoplasms/epidemiology*
;
Oropharyngeal Neoplasms/epidemiology*
;
Papillomaviridae
2.Dexmedetomidine can not reduce the incidence of acute and chronic kidney disease after laparoscopic radical nephrectomy: a propensity score matching-based analysis.
Yuwei SU ; Wen SUN ; Di WANG ; Yuyan DONG ; Ying DING ; Longhe XU ; Yongzhe LIU
Journal of Southern Medical University 2023;43(4):654-659
OBJECTIVE:
To investigate the effect of dexmedetomidine (DEX) on renal function after laparoscopic radical nephrectomy.
METHODS:
We reviewed the clinical data of 282 patients with renal cell carcinoma (RCC), who underwent laparoscopic radical nephrectomy (LRN) in the Department of Urology, Third Medical Center of PLA General Hospital from November, 2020 and June, 2022.According to whether DEX was used during the operation, the patients were divided into DEX group and control group, and after propensity score matching, 99 patients were finally enrolled in each group.The incidence of acute kidney injuries were compared between the two groups.Serum creatinine (sCr) data within 3 months to 1 year after the operation were available in 51 patients, including 26 in DEX group and 25 in the control group, and the incidence of chronic kidney disease (CKD) was compared between the two groups.
RESULTS:
After propensity score matching and adjustment for significant covariates, there were no significant differences in postoperative levels of sCr, cystatin C (CysC), β2-microglobulin (β2-MG), hemoglobin (Hb), or C-reactive protein (CRP), extubation time, incidence of AKI, or length of hospital stay between the two groups (P>0.05).The intraoperative urine volume was significantly higher in DEX group than in the control group (P < 0.05).A significant correlation between AKI and CKD was noted in the patients (P < 0.05).The incidence of CKD did not differ significantly between the two groups (P>0.05).
CONCLUSION
DEX can not reduce the incidence of AKI or CKD after LRN.
Humans
;
Dexmedetomidine
;
Incidence
;
Propensity Score
;
Renal Insufficiency, Chronic/epidemiology*
;
Kidney Neoplasms/surgery*
;
Nephrectomy/adverse effects*
;
Laparoscopy/adverse effects*
;
Acute Kidney Injury/prevention & control*
;
Retrospective Studies
3.Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience.
Karuppiah VIJAYALAKSHMI ; Anne Hui Yi GOEI
Singapore medical journal 2023;64(5):294-301
INTRODUCTION:
Cervical cancer has a high disease burden in Singapore, and it is strongly associated with human papillomavirus (HPV) infections. Despite constant efforts to encourage vaccination, local HPV vaccine uptake remains low. Universal mass vaccination is a proven cost-effective method to reduce the cervical cancer disease burden. This paper reviews the newly implemented school-based HPV vaccination programme in Singapore and the factors that led to its success.
METHODS:
Fully subsidised HPV vaccinations were offered to all Secondary 1 female students on an opt-in basis, starting as a rollout dose in 2019. One-time catchup vaccination was also offered to female students in Secondary 2-5. Eligible recipients were identified using enrolment data provided by Ministry of Education schools. A total of 19,144 students across 139 schools were offered the rollout dose, and 20,854 students across 140 schools were offered the catchup doses.
RESULTS:
High vaccine uptake rates of 80.6%-87.3% were noted with the introduction of the school-based programme, translating to high vaccine coverage of 90.3%-93.4%. Only a small proportion of students (1.5%-1.9% per cohort) opted out. The rate of reported side effects, which were commonly known effects, was low at one in 1000. Among the students who reported side effects, those who received the second vaccine dose did so uneventfully.
CONCLUSION
High HPV vaccine coverage was achieved after implementation of the school-based immunisation programme. Timely assessment of knowledge lapses and targeted intervention, strong partnerships with stakeholders, constant on-site adaptation and positive social influence contributed to its success. This model can be applied to future school health programmes.
Humans
;
Female
;
Papillomavirus Vaccines/therapeutic use*
;
Human Papillomavirus Viruses
;
Papillomavirus Infections/prevention & control*
;
Singapore
;
Uterine Cervical Neoplasms/epidemiology*
;
Vaccination
;
Immunization Programs
4.Consensus on the clinical diagnosis, treatment, and prevention of cancer related anemia in China (2023 edition).
Chinese Journal of Oncology 2023;45(12):1032-1040
Cancer related anemia (CRA) is a common side effect in patients with tumors, the incidence of which is related to tumor type, treatment regimen, the duration of chemotherapy, etc. The pathogenesis of CRA has not been fully defined. CRA may lead to chemotherapy dose reduction or may even delay chemotherapy. Patients with CRA require red blood cell transfusion, thus increasing the treatment cost, reducing the efficiency of chemotherapy and the patient's quality of life, and shortening the survival time. The main treatments of CRA include red blood cell transfusion, iron supplements, erythropoietin, and so on. Based on recent literature and clinical studies, the expert committee of the China Anti-Cancer Association drew up the consensus on the diagnosis and treatment of anemia related to tumor in China (2023 edition). The 2023 consensus incorporates the latest evidence-based medicine evidence and Traditional Chinese Medicine related content and aims to provide more reliable diagnosis and treatment plans for Chinese oncologists to help improve CRA and the quality of life in patients with cancer.
Humans
;
Consensus
;
Quality of Life
;
Anemia/prevention & control*
;
Neoplasms/therapy*
;
China/epidemiology*
5.The Lifelong Health Support 10: a Japanese prescription for a long and healthy life.
Ahmed ARAFA ; Yoshihiro KOKUBO ; Rena KASHIMA ; Masayuki TERAMOTO ; Yukie SAKAI ; Saya NOSAKA ; Youko M NAKAO ; Emi WATANABE
Environmental Health and Preventive Medicine 2022;27(0):23-23
BACKGROUND:
Although the age-adjusted incidence and mortality of cancer and cardiovascular disease (CVD) have been decreasing steadily in Japan, both diseases remain major contributors to morbidity and mortality along with the aging society. Herein, we aim to provide a prescription of 10 health tips for long and healthy life named the "Lifelong Health Support 10 (LHS10)."
METHOD:
The LHS10 was developed by the preventive medicine specialists at the National Cerebral and Cardiovascular Center in Suita, where it has been used for health guidance to prevent CVD, cancer, and cognitive decline in addition to their major risk factors such as hypertension, diabetes, and obesity. It consisted of the lifestyle modification recommendations of the 2014 Japanese Society of Hypertension guidelines and the 2017 Japan Atherosclerosis Society Guidelines for preventing atherosclerotic CVD. Further, it came in line with other international lifestyle modification guidelines. In this narrative review, we summarized the results of several Japanese epidemiological studies investigating the association between the LHS10 items and the risk of cancer, CVD, and other chronic diseases including dementia, diabetes, and chronic kidney disease.
RESULTS:
The LHS10 included avoiding smoking and secondhand smoke exposure, engaging in physical activity, refraining from excessive alcohol drinking, reducing fried foods and sugary soft drinks, cutting salt in food, consuming more vegetables, fruits, fish, soy foods, and fibers, and maintaining proper body weight. All items of the LHS10 were shown to reduce the risk of cancer, CVD, and other chronic diseases.
CONCLUSIONS
The LHS10 can be a helpful tool for health guidance.
Cardiovascular Diseases/prevention & control*
;
Humans
;
Hypertension/prevention & control*
;
Japan/epidemiology*
;
Life Style
;
Neoplasms
;
Prescriptions
;
Risk Factors
6.Causes and countermeasures of the rapidly rising burden on cervical cancer in Chinese women.
Hao CHEN ; Chang Fa XIA ; Ting Ting YOU ; You Lin QIAO ; Fang Hui ZHAO
Chinese Journal of Epidemiology 2022;43(5):761-765
The world is entering a new era of accelerated elimination of cervical cancer, while the age-standardized incidence, and mortality of cervical cancer in China are rising rapidly. This article summarizes and describes the current situation and trends of the burden of cervical cancer in China, reviews and analyzes the comprehensive prevention practice of cervical cancer, focusing on critical reasons for the increasing burden of cervical cancer, from the perspectives of sociology, behavior, and epidemiology in the population. Countermeasures are proposed to provide guidance and theoretical reference for the precise prevention of cervical cancer to eliminate cervical cancer.
Asians
;
Causality
;
China/epidemiology*
;
Female
;
Humans
;
Incidence
;
Uterine Cervical Neoplasms/prevention & control*
7.China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing).
Jie HE ; Wan Qing CHEN ; Zhao Shen LI ; Ni LI ; Jian Song REN ; Jin Hui TIAN ; Wen Jing TIAN ; Fu Lan HU ; Ji PENG
Chinese Journal of Oncology 2022;44(6):491-522
Esophageal cancer (EC) is a major digestive tract malignancy in China, which seriously threatens the health of Chinese population. A large number of researches have demonstrated that screening and early detection are effective in reducing the incidence and mortality of EC. The development of the guideline for EC screening and early detection in line with epidemic characteristics of EC in China will greatly promote the homogeneity and standardization, and improve the effect of EC screening. This guideline was commissioned by the Bureau of Disease Control and Prevention of the National Health Commission. The National Cancer Center of China initiated and convened a working group comprising multidisciplinary experts. Following the World Health Organization Handbook for Guideline Development, this guideline combined the most up-to-date evidence of EC screening, China's national conditions, and practical experience in cancer screening. This guideline provided evidence-based recommendations with respect to the screening population, technology and procedure management, aiming to improve the effect of EC screening and provide scientific evidence for the EC prevention and control in China.
Beijing
;
China/epidemiology*
;
Early Detection of Cancer/methods*
;
Esophageal Neoplasms/prevention & control*
;
Humans
;
Mass Screening
8.China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing).
Jie HE ; Wan Qing CHEN ; Zhao Shen LI ; Ni LI ; Jian Song REN ; Jin Hui TIAN ; Wen Jing TIAN ; Fu Lan HU ; Ji PENG
Chinese Journal of Oncology 2022;44(7):634-666
Gastric cancer (GC) is a major digestive tract malignancy in China, which seriously threatens the health of Chinese population. A large number of researches have demons-trated that screening, early detection and early treatment are effective in reducing the incidence and mortality of GC. The development of the guideline for GC screening, early detection and early treatment in line with epidemic characteristics of GC in China will greatly promote the homogeneity and standardization, and improve the effect of GC screening. This guideline was commissioned by the Bureau of Disease Control and Prevention of the National Health Commission. The National Cancer Center of China initiated and convened a working group comprising multidisciplinary experts. Following the World Health Organization Handbook for Guideline Development, this guideline combined the most up-to-date evidence of GC screening, China's national conditions, and practical experience in cancer screening. This guideline provided evidence-based recommendations with respect to the screening population, technology and procedure management, aiming to improve the effect of GC screening and provide scientific evidence for the GC prevention and control in China.
Beijing
;
China/epidemiology*
;
Early Detection of Cancer/methods*
;
Humans
;
Mass Screening
;
Stomach Neoplasms/prevention & control*
9.The consensus on tertiary prevention of primary liver cancer (2022 version).
Chinese Journal of Hepatology 2022;30(8):832-845
In order to effectively prevent recurrence, improve the prognosis and increase the survival rate of primary liver cancer (PLC) patients with radical cure, the Chinese Society of Hepatology, Chinese Medical Association organized the relevant experts to develop the consensus on tertiary prevention of PLC (2022 version), which based on domestic and international research progress on the risk factors, pathological and clinical features, prevention of recurrence of PLC, combined with the present actual situation in China. The purpose is to provide a current basis for the prevention, surveillance, early detection and diagnosis, the effective measures of PLC recurrence.
China/epidemiology*
;
Consensus
;
Humans
;
Liver Neoplasms/prevention & control*
;
Survival Rate
;
Tertiary Prevention
10.Current situation and prospect of primary prevention of cancer in China.
Huang HUANG ; Pei Yuan SUN ; Kai Yong ZOU ; Jie HE ; Ya Wei ZHANG
Chinese Journal of Oncology 2022;44(9):942-949
Cancer is a major public health issue that seriously endangers the public health and social development of China. Future initiatives for cancer prevention and control should continue to adhere to the principle of prioritizing prevention, and comprehensively implement related prevention activities nationwide. This is critical to reducing cancer burden in Chinese residents, especially in the low- and middle-income populations and those living in areas that are less economically developed. In the past several decades, the international community has significantly reduced the incidence of related cancers through primary prevention measures such as tobacco control, improved occupational hygiene, and vaccination. China has also implemented a series of exploratory primary prevention measures among high-risk groups of cancer in specific areas including Xuanwei, Qidong, and Linxian, and achieved encouraging results. However, due to the low level of systematic awareness of cancer risk factors and the lack of awareness and ability of self-health management in Chinese residents, it is urgent to develop novel research tools and methods to further reveal the causes of cancer, and establish innovative mechanisms and systems of primary prevention of cancer at population and individual levels. Based on current status of the transformation of cancer spectrum and the development of digital intelligence, it would be beneficial to establish a smart digital system for primary cancer prevention service that can cover the entire population, integrating authoritative popular science education on primary prevention of cancer, individualized cancer risk assessment, and personalized health management assistant. This will improve primary cancer prevention among the Chinese general population and can help the sustainable development of cancer prevention and control in China.
China/epidemiology*
;
Delivery of Health Care
;
Humans
;
Neoplasms/prevention & control*
;
Primary Prevention
;
Risk Factors

Result Analysis
Print
Save
E-mail